(Total Views: 452)
Posted On: 09/10/2018 3:11:23 PM
Post# of 30066
.jpg)
SeD updates. Since we're still very much under CHF's thumb, it's good to keep up with them for insights.
Their property businesses have lagged of late.
No idea if we used them, but SeD Biomedical recently used Destum Partners to place a valuation on their "linebacker" and "laetose" assets, both at around 300million. http://www.destumpartners.com/
SeD's GSMS fund also now has external institutional investors.
http://infopub.sgx.com/FileOpen/SeD-Corporate...eID=511044
Further, Infusion 51a has beein looking to add people to their team recently, and also posted a job for the Vivacitas CEO recently. We still have a lot of personnel overlap with Vivacitas.
Their property businesses have lagged of late.
No idea if we used them, but SeD Biomedical recently used Destum Partners to place a valuation on their "linebacker" and "laetose" assets, both at around 300million. http://www.destumpartners.com/
SeD's GSMS fund also now has external institutional investors.
http://infopub.sgx.com/FileOpen/SeD-Corporate...eID=511044
Further, Infusion 51a has beein looking to add people to their team recently, and also posted a job for the Vivacitas CEO recently. We still have a lot of personnel overlap with Vivacitas.
(0)
(0)
